Literature DB >> 25663422

The renin-angiotensin system and prevention of age-related functional decline: where are we now?

Corey B Simon1, Brittany Lee-McMullen, Dane Phelan, Janine Gilkes, Christy S Carter, Thomas W Buford.   

Abstract

Declining physical function is a major health problem for older adults as it is associated with multiple comorbidities and mortality. Exercise has been shown to improve physical function, though response to exercise is variable. Conversely, drugs targeting the renin-angiotensin system (RAS) pathway, including angiotensin-converting enzyme inhibitors (ACEi) and angiotensin receptor blockers (ARBs), are also reported to improve physical function. In the past decade, significant strides have been made to understand the complexity and specificity of the RAS system as it pertains to physical function in older adults. Prior findings have also determined that interactions between antihypertensive medications and exercise may influence physical function above and beyond either factor alone. We review the latest research on RAS, exercise, and physical function for older adults. We also outline future research aims in this area, including genetic influences and clinical phenotyping, for the purpose of maintaining or improving physical function through tailored treatments.

Mesh:

Year:  2015        PMID: 25663422      PMCID: PMC4320995          DOI: 10.1007/s11357-015-9753-5

Source DB:  PubMed          Journal:  Age (Dordr)        ISSN: 0161-9152


  105 in total

Review 1.  Angiotensin-(1-7) as an antihypertensive, antifibrotic target.

Authors:  Michael J Katovich; Justin L Grobe; Mohan K Raizada
Journal:  Curr Hypertens Rep       Date:  2008-06       Impact factor: 5.369

Review 2.  Angiotensin-(1-7).

Authors:  Robson Augusto Santos
Journal:  Hypertension       Date:  2014-03-24       Impact factor: 10.190

3.  Late-life enalapril administration induces nitric oxide-dependent and independent metabolic adaptations in the rat skeletal muscle.

Authors:  Emanuele Marzetti; Riccardo Calvani; Jameson DuPree; Hazel A Lees; Silvia Giovannini; Dong-oh Seo; Thomas W Buford; Kindal Sweet; Drake Morgan; Kevin Y E Strehler; Debra Diz; Stephen E Borst; Natasha Moningka; Karina Krotova; Christy S Carter
Journal:  Age (Dordr)       Date:  2012-05-26

Review 4.  Subcellular characteristics of functional intracellular renin-angiotensin systems.

Authors:  Peter M Abadir; Jeremy D Walston; Robert M Carey
Journal:  Peptides       Date:  2012-09-29       Impact factor: 3.750

Review 5.  Angiotensin-(1-7): beyond the cardio-renal actions.

Authors:  Danielle G Passos-Silva; Thiago Verano-Braga; Robson A S Santos
Journal:  Clin Sci (Lond)       Date:  2013-04       Impact factor: 6.124

Review 6.  Brain renin-angiotensin system in the nexus of hypertension and aging.

Authors:  Amy C Arnold; Patricia E Gallagher; Debra I Diz
Journal:  Hypertens Res       Date:  2012-10-18       Impact factor: 3.872

7.  Genetic influence on exercise-induced changes in physical function among mobility-limited older adults.

Authors:  Thomas W Buford; Fang-Chi Hsu; Tina E Brinkley; Christy S Carter; Timothy S Church; John A Dodson; Bret H Goodpaster; Mary M McDermott; Barbara J Nicklas; Veronica Yank; Julie A Johnson; Marco Pahor
Journal:  Physiol Genomics       Date:  2014-01-14       Impact factor: 3.107

8.  The effects of angiotensin receptor blockers vs. calcium channel blockers on the acute exercise-induced inflammatory and thrombotic response.

Authors:  Charalampos I Liakos; Gregory P Vyssoulis; Andreas P Michaelides; Evangelos I Chatzistamatiou; George Theodosiades; Marina G Toutouza; Maria I Markou; Andreas G Synetos; Ioannis E Kallikazaros; Christodoulos I Stefanadis
Journal:  Hypertens Res       Date:  2012-09-06       Impact factor: 3.872

9.  Do ACE inhibitors improve the response to exercise training in functionally impaired older adults? A randomized controlled trial.

Authors:  Deepa Sumukadas; Margaret Band; Suzanne Miller; Vera Cvoro; Miles Witham; Allan Struthers; Alex McConnachie; Suzanne M Lloyd; Marion McMurdo
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2013-11-07       Impact factor: 6.053

10.  Association of cardiovascular response to an acute resistance training session with the ACE gene polymorphism in sedentary women: a randomized trial.

Authors:  Jéssica Cardoso de Souza; Ramires Alsamir Tibana; Nuno Manuel Frade de Sousa; Vinícius Carolino de Souza; Margô G O Karnikowski; Jonato Prestes; Carmen Silvia Grubert Campbell
Journal:  BMC Cardiovasc Disord       Date:  2013-01-10       Impact factor: 2.298

View more
  15 in total

Review 1.  The role of the cell-matrix interface in aging and its interaction with the renin-angiotensin system in the aged vasculature.

Authors:  Maria De Luca
Journal:  Mech Ageing Dev       Date:  2018-04-04       Impact factor: 5.432

Review 2.  The Gut Microbiome as a Therapeutic Target for Cognitive Impairment.

Authors:  Yi Sun; Liliana C Baptista; Lisa M Roberts; Patricia Jumbo-Lucioni; Lori L McMahon; Thomas W Buford; Christy S Carter
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2020-06-18       Impact factor: 6.053

3.  Chymase-dependent production of angiotensin II: an old enzyme in old hearts.

Authors:  Ghezal Froogh; John T Pinto; Yicong Le; Sharath Kandhi; Yeabsra Aleligne; An Huang; Dong Sun
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-11-04       Impact factor: 4.733

4.  Multi-modal intervention to reduce cardiovascular risk among hypertensive older adults: Design of a randomized clinical trial.

Authors:  Thomas W Buford; Stephen D Anton; Anthony A Bavry; Christy S Carter; Michael J Daniels; Marco Pahor
Journal:  Contemp Clin Trials       Date:  2015-06-23       Impact factor: 2.226

5.  Probiotic Releasing Angiotensin (1-7) in a Drosophila Model of Alzheimer's Disease Produces Sex-Specific Effects on Cognitive Function.

Authors:  C Aaron Smith; Haddon Smith; Lisa Roberts; Lori Coward; Gregory Gorman; Amrisha Verma; Qiuhong Li; Thomas W Buford; Christy S Carter; Patricia Jumbo-Lucioni
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

6.  Guideline-Recommended Medications and Physical Function in Older Adults with Multiple Chronic Conditions.

Authors:  Gail McAvay; Heather G Allore; Andrew B Cohen; Danijela Gnjidic; Terrence E Murphy; Mary E Tinetti
Journal:  J Am Geriatr Soc       Date:  2017-09-14       Impact factor: 5.562

7.  Predictors of Change in Physical Function in Older Adults in Response to Long-Term, Structured Physical Activity: The LIFE Study.

Authors:  Andrew S Layne; Fang-Chi Hsu; Steven N Blair; Shyh-Huei Chen; Jennifer Dungan; Roger A Fielding; Nancy W Glynn; Alexandra M Hajduk; Abby C King; Todd M Manini; Anthony P Marsh; Marco Pahor; Christine A Pellegrini; Thomas W Buford
Journal:  Arch Phys Med Rehabil       Date:  2016-08-25       Impact factor: 3.966

8.  Circulating IGF-1 deficiency exacerbates hypertension-induced microvascular rarefaction in the mouse hippocampus and retrosplenial cortex: implications for cerebromicrovascular and brain aging.

Authors:  Stefano Tarantini; Zsuzsanna Tucsek; M Noa Valcarcel-Ares; Peter Toth; Tripti Gautam; Cory B Giles; Praveen Ballabh; Jeanne Y Wei; Jonathan D Wren; Nicole M Ashpole; William E Sonntag; Zoltan Ungvari; Anna Csiszar
Journal:  Age (Dordr)       Date:  2016-09-09

9.  Comparative Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Response to a Physical Activity Intervention in Older Adults: Results From the Lifestyle Interventions and Independence for Elders Study.

Authors:  Joshua D Brown; Steven M Smith; Elsa S Strotmeyer; Stephen B Kritchevsky; Thomas M Gill; Steven N Blair; Roger A Fielding; Thomas W Buford; Marco Pahor; Todd M Manini
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2020-04-17       Impact factor: 6.053

10.  Age- and Genotype-Specific Effects of the Angiotensin-Converting Enzyme Inhibitor Lisinopril on Mitochondrial and Metabolic Parameters in Drosophila melanogaster.

Authors:  Karis A Ederer; Kelly Jin; Sarah Bouslog; Lu Wang; Gregory S Gorman; Glenn C Rowe; Peter Abadir; Daniel Raftery; Douglas Moellering; Daniel Promislow; Patricia Jumbo-Lucioni; Maria De Luca
Journal:  Int J Mol Sci       Date:  2018-10-26       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.